NLRP3 and pancreatic intraductal papillary-mucinous neoplasm: In intestinal IPMN, enhanced NLRP3 priming appears to play a role in malignant transformation whereas, in nonintestinal cases, caspase‐1 activation and IL‐18‐driven immunosuppression may contribute to malignant degeneration.